Introduction: Hypertension (HT) can be the cause or consequence of chronic kidney disease. Its management often requires a multiple therapy due to its severity. Objective: To describe the profile of patients receiving a multiple anti-hypertensive therapy in nephrology practice. Materials and Methods: This was a prospective, descriptive study conducted in the department of Nephrology, Yopougon Teaching Hospital, from January 1 to October 31, 2016. We included all patients admitted to this department who had received at least three anti-hypertensive drugs. Results: Out of a total of 625 hypertensive patients admitted over the study period, we included 120 patients on multiple therapy, i.e. a 19% prevalence. HT was essential in 60% of cases, secondary to chronic glomerulonephritis (CGN) in 25%, to diabetes in 13.3% and to polycystic kidney disease (PKD) in 1.7%. The therapy consisted of the combination of 3 antihy-pertensive drugs in 36.7% of cases, 4 drugs in 49.2% and 5 drugs in 4.2%. The antihypertensive classes used were Calcium channel blockers (CCB) in 99.2% of cases, Diuretics (D) in 87.5%, Angiotensin Converting Enzyme Inhibitors (ACEI) in 70%, Centrally acting medication (C) in 66.7%, Angiotensin Receptor Blockers (ARB) in 25.8% and Beta-blockers (β-) in 6.7%. The main combinations were CCB + D + ACEI + C in 34.2% of cases, CCB + D + ACEI in 23.3%, and CCB + D + ARB + C in 12.5%. The combinations of antihypertensive drugs varied according to the cause of HT with a non-significant difference. Patient outcome was characterized by normal blood pressure in 64.2% of cases and normal renal function in 13.3%. The mortality rate was 17.5%. In multivariate analysis, stage 5 renal disease (p = 0.001), hypertensive retinopathy (p = 0.04) and hemoglobin level < 8 g/dl (p = 0.039) were associated with mortality. Conclusion: Multiple antihypertensive therapy, which is common in nephrology, is related to the severity of HT and not to its cause. We still use centrally acting drugs in combination with the other recommended classes, so as to achieve the target blood pressure.
KeywordsHypertensionMultiple TherapyNephrology
Blacher, J., Halami, J.-M., Hanon, O., Mourad, J.-J., Pathak, A., Schenebert, B. and Gired, X. (2013) Guidelines on the Management of Adult Hypertension, French Society of Hypertension. http://www.sfhta.eu/
Couchoud, C., Lassalle, M. and Jacqueline, C. (2013) Report Rein 2011—Synthesis. Nephrologie & Therapeutique, 9, S3-S6. https://doi.org/10.1016/S1769-7255(13)70036-1
Ouattara, B., Kra, O., Yao, H., Kadjo, K. and Niamkey, E.K. (2011) Particularities of Chronic Renal Failure in Black Adult Patients Hospitalized in Internal Medicine of Treichville University Hospital. Nephrologie & Therapeutique, 7, 531-534. https://doi.org/10.1016/j.nephro.2011.03.009
Hannedouche, T. (2015) Hypertension and Kidney. Hypertension Magazine, 4, 5-7.
World Health Organization—International Society of Hypertension Guidelines for the Management of Hypertension (1999) Guidelines Sub-Committee of the World Health Organization. Clinical and Experimental Hypertension, 21, 1009-1060.
Abel, N., Contino, K., Jain, N., Grewal, N., Grand, E., Hagans, I., Hunter, K. and Roy, S. (2015) Eighth Joint National Committee (JNC-8) Guidelines and the Outpatient Management of Hypertension in the African-American Population. The American Journal of the Medical Sciences, 7, 438-445. https://doi.org/10.4103/1947-2714.168669
American Diabetes Association (2015) Part2. Classification and Diagnosis of Diabetes. Diabetes Care, 38, S8-S16. https://doi.org/10.2337/dc15-S005
National Kidney Foundation (2002) K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. American Journal of Kidney Diseases, 39, S1-S266.
KDIGO (2012) Clinical Practice Guideline for Glomerulonephritis. Kidney International, 2, 1-143.
Standards of Medical Care (2011) Standards of Medical Care in Diabetes—2011. Diabetes Care, 34, S11-S61. https://doi.org/10.2337/dc11-S011
Noël, N. and Rieu, P. (2015) Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis and Treatment Options for Autosomal Dominant Polycystic Kidney Disease. Nephrologie & Therapeutique, 11, 213-225.
Yao, K.H., Sanogo, S., Binan, A.Y.O., Hue Lou, A. and Diallo, A.D. (2012) Complicated Novo Hypertension in Adults in Black African Hospital. Medecine d’Afrique Noire, 59, 199-203.
Koffi, J., N’Goran, Y., Bamba-kamagaté, D., N’Djessan, J.J. and Anzouan-Kacou, J.B. (2005) The Value of Therapeutic Education in Adherence to Antihypertensive Therapy in the Black Subject. The African Journal of the Thorax and Vessels, 32.
Olanrewaju, T.O., Aderibigbe, A., Busari, O.A. and Sanya, E.O. (2010) Antihypertensive Drug Utilization and Conformity to Guidelines in a Sub-Saharan African Hypertensive Population. International Journal of Clinical Pharmacology and Therapeutics, 48, 68-75. https://doi.org/10.5414/CPP48068
Wang, Z., Wang, X., Chen, Z., Wang, W., Zhu, H., Chen, W., Zhu, M., Hu, S., Staessen, J.A., Liu, L. and Fodor, J.G., Hypertension Control in Community Health Center Project Group (2014) Hypertension Control in Community Health Centers across China: Analysis of Antihypertensive Drug Treatment Patterns. American Journal of Hypertension, 27, 252-259. https://doi.org/10.1093/ajh/hpt186
Viera, A.J. and Neutze, D.M. (2010) Diagnosis of Secondary Hypertension: An Age-Based Approach. American Family Physician, 82, 1471-1478.
Ojji, D.B., Ajayi, S.O., Mamven, M.H., Alfa, J. and Albertino, D. (2013) Pattern of Prescription of Anti-Hypertensive Medications in a Tertiary Health Care Facility in Abuja, Nigeria. Ethnicity & Disease, 23, 480-483.
Xu, H., He, Y., Xu, L., Yan, X. and Dai, H. (2015) Trends and Patterns of Five Antihypertensive Drug Classes between 2007 and 2012 in China using Hospital Prescription Data. International Journal of Clinical Pharmacology and Therapeutics, 53, 430-437. https://doi.org/10.5414/CP202243
Bhargava, M., Ikram, M.K. and Wong, T.Y. (2012) How Does Hypertension Affect Your Eyes? Journal of Human Hypertension, 26, 71-83. https://doi.org/10.1038/jhh.2011.37
Grunwald, J.E., Ying, G.S., Maguire, M., Pistilli, M., Daniel, E., Alexander, J., Whittock-Martin, R., et al. (2012) Association between Retinopathy and Cardiovascular Disease in Patients with Chronic Kidney Disease (from the Chronic Renal Insufficiency Cohort [CRIC] Study). American Journal of Cardiology, 110, 246-253.
Wong, T.Y., Coresh, J., Klein, R., Muntner, P., Couper, D.J., Sharrett, A.R., Klein, B.E., Heiss, G., Hubbard, L.D. and Duncan, B.B. (2004) Retinal Microvascular Abnormalities and Renal Dysfunction: The Atherosclerosis Risk in Communities Study. Journal of the American Society of Nephrology, 15, 2469-2476. https://doi.org/10.1097/01.ASN.0000136133.28194.E4
Ricardo, A.C., Grunwald, J.E., Parvathaneni, S., Goodin, S., Ching, A. and Lash, J.P. (2014) Retinopathy and CKD as Predictors of All-Cause and Cardiovascular Mortality: National Health and Nutrition Examination Survey (NHANES) 1988-1994. American Journal of Kidney Diseases, 64, 198-203. https://doi.org/10.1053/j.ajkd.2014.01.437
Glynn, L.G., Reddan, D., Newell, J., Hinde, J., Buckley, B. and Murphy, A.W. (2007) Chronic Kidney Disease and Mortality and Morbidity among Patients with Established Cardiovascular Disease: A West of Ireland Community-Based Cohort Study. Nephrology Dialysis Transplantation, 22, 2586-2594. https://doi.org/10.1093/ndt/gfm222
Horwich, T.B., Fonarow, G.C., Hamilton, M.A., MacLellan, W.R. and Borenstein, J. (2002) Anemia Is Associated with Worse Symptoms, Greater Impairment in Functional Capacity and a Significant Increase in Mortality in Patients with Advanced Heart Failure. Journal of the American College of Cardiology, 39, 1780-1786.
Young, J.B., Abraham, W.T., Albert, N.M., Gattis Stough, W., Gheorghiade, M., Greenberg, B.H., O’Connor, C.M., She, L., Sun, J.L., Yancy, C.W., et al. (2008) Relation of Low Hemoglobin and Anemia to Morbidity and Mortality in Patients Hospitalized with Heart Failure (Insight from the OPTIMIZE-HF Registry). American Journal of Cardiology, 101, 223-230.
Anderson, J., Glynn, L.G., Newell, J., Iglesias, A.A., Reddan, D. and Murphy, A.W. (2009) The Impact of Renal Insufficiency and Anaemia on Survival in Patients with Cardiovascular Disease: A Cohort Study. BMC Cardiovascular Disorders, 9, 51. https://doi.org/10.1186/1471-2261-9-51